338 related articles for article (PubMed ID: 11483769)
1. Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients.
Maillard P; Krawczynski K; Nitkiewicz J; Bronnert C; Sidorkiewicz M; Gounon P; Dubuisson J; Faure G; Crainic R; Budkowska A
J Virol; 2001 Sep; 75(17):8240-50. PubMed ID: 11483769
[TBL] [Abstract][Full Text] [Related]
2. Characterization of three novel monoclonal antibodies against hepatitis C virus core protein.
Moradpour D; Wakita T; Tokushige K; Carlson RI; Krawczynski K; Wands JR
J Med Virol; 1996 Mar; 48(3):234-41. PubMed ID: 8801283
[TBL] [Abstract][Full Text] [Related]
3. HCV core immunodominant region analysis using mouse monoclonal antibodies and human sera: characterization of major epitopes useful for antigen detection.
Jolivet-Reynaud C; Dalbon P; Viola F; Yvon S; Paranhos-Baccala G; Piga N; Bridon L; Trabaud MA; Battail N; Sibai G; Jolivet M
J Med Virol; 1998 Dec; 56(4):300-9. PubMed ID: 9829633
[TBL] [Abstract][Full Text] [Related]
4. Recombinant hepatitis C virus-like particles expressed by baculovirus: utility in cell-binding and antibody detection assays.
Xiang J; Wünschmann S; George SL; Klinzman D; Schmidt WN; LaBrecque DR; Stapleton JT
J Med Virol; 2002 Dec; 68(4):537-43. PubMed ID: 12376962
[TBL] [Abstract][Full Text] [Related]
5. [Comparative analysis of hepatitis C virus core protein in the plasma and serum samples from HCV-infected blood donors and patients with hepatitis C].
Masalova OV; Vishnevskaia TV; Shkurko TV; Garanzha TA; Tupoleva TA; Filatov FP; Blokhina NP; Kushch AA
Vopr Virusol; 2007; 52(4):11-7. PubMed ID: 17722604
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin G and M hepatitis C virus core antibody (JCC.2) response in chimpanzees infected experimentally with hepatitis C virus.
Shioda A; Moriyama M; Hayashi N; Sugitani M; Uchida T; Shikata T; Nishizono A; Abe K; Arakawa Y
Intervirology; 2000; 43(3):146-53. PubMed ID: 11044808
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees.
Shata MT; Anthony DD; Carlson NL; Andrus L; Brotman B; Tricoche N; McCormack P; Prince A
J Viral Hepat; 2002 Nov; 9(6):400-10. PubMed ID: 12431201
[TBL] [Abstract][Full Text] [Related]
8. High efficiency prokaryotic expression and purification of a portion of the hepatitis C core protein and analysis of the immune response to recombinant protein in BALB/c mice.
Hitomi Y; McDonnell WM; Baker JR; Askari FK
Viral Immunol; 1995; 8(2):109-19. PubMed ID: 8825296
[TBL] [Abstract][Full Text] [Related]
9. No requirement of HCV 5'NCR for HCV-like particles assembly in insect cells.
Zhao W; Liao GY; Jiang YJ; Jiang SD
World J Gastroenterol; 2003 Oct; 9(10):2226-31. PubMed ID: 14562383
[TBL] [Abstract][Full Text] [Related]
10. Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C.
Baumert TF; Wellnitz S; Aono S; Satoi J; Herion D; Tilman Gerlach J; Pape GR; Lau JY; Hoofnagle JH; Blum HE; Liang TJ
Hepatology; 2000 Sep; 32(3):610-7. PubMed ID: 10960457
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies with broad specificity for hepatitis C virus hypervariable region 1 variants can recognize viral particles.
Cerino A; Meola A; Segagni L; Furione M; Marciano S; Triyatni M; Liang TJ; Nicosia A; Mondelli MU
J Immunol; 2001 Oct; 167(7):3878-86. PubMed ID: 11564805
[TBL] [Abstract][Full Text] [Related]
12. Detection of hepatitis C core antigen in the antibody negative 'window' phase of hepatitis C infection.
Peterson J; Green G; Iida K; Caldwell B; Kerrison P; Bernich S; Aoyagi K; Lee SR
Vox Sang; 2000; 78(2):80-5. PubMed ID: 10765142
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of a hepatitis C virus-specific antigen predicted from the putative core gene in the circulation of infected hosts.
Takahashi K; Okamoto H; Kishimoto S; Munekata E; Tachibana K; Akahane Y; Yoshizawa H; Mishiro S
J Gen Virol; 1992 Mar; 73 ( Pt 3)():667-72. PubMed ID: 1312124
[TBL] [Abstract][Full Text] [Related]
14. p26 protein and 33-nm particle associated with nucleocapsid of hepatitis C virus recovered from the circulation of infected hosts.
Takahashi K; Kishimoto S; Yoshizawa H; Okamoto H; Yoshikawa A; Mishiro S
Virology; 1992 Nov; 191(1):431-4. PubMed ID: 1329328
[TBL] [Abstract][Full Text] [Related]
15. Immune response to epitopes of hepatitis C virus (HCV) structural proteins in HCV-infected humans and chimpanzees.
Wang YF; Brotman B; Andrus L; Prince AM
J Infect Dis; 1996 Apr; 173(4):808-21. PubMed ID: 8603958
[TBL] [Abstract][Full Text] [Related]
16. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus structural proteins assemble into viruslike particles in insect cells.
Baumert TF; Ito S; Wong DT; Liang TJ
J Virol; 1998 May; 72(5):3827-36. PubMed ID: 9557666
[TBL] [Abstract][Full Text] [Related]
18. Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients.
Missale G; Cariani E; Lamonaca V; Ravaggi A; Rossini A; Bertoni R; Houghton M; Matsuura Y; Miyamura T; Fiaccadori F; Ferrari C
Hepatology; 1997 Sep; 26(3):792-7. PubMed ID: 9303515
[TBL] [Abstract][Full Text] [Related]
19. Expression of the full-length HCV core subgenome from HCV gentoype-1a and genotype-3a and evaluation of the antigenicity of translational products.
Ansari MA; Irshad M; Agarwal SK; Chosdol K
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):806-13. PubMed ID: 23442416
[TBL] [Abstract][Full Text] [Related]
20. Detection of hepatitis C virus core protein circulating within different virus particle populations.
Masalova OV; Atanadze SN; Samokhvalov EI; Petrakova NV; Kalinina TI; Smirnov VD; Khudyakov YE; Fields HA; Kushch AA
J Med Virol; 1998 May; 55(1):1-6. PubMed ID: 9580878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
